Clinical Trial Update: A Study to Assess the Effects of Dissolution Profile on the Pharmacokinetics of Single Oral Doses of Tafenoquine Tablets and Tafenoquine Stable Isotope Labelled Solution [Phase 1]

View source ↗

Summary

Phase 1 study assessing how the dissolution profile influences the pharmacokinetics of single oral doses of Tafenoquine tablets and a Tafenoquine stable isotope…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Vivax Malaria

Drugs mentioned

• Tafenoquine (tafenoquine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Malaria, Vivax | Phase 1 | Status: COMPLETED